Christine M. Parseghian

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Christine M. Parseghian, Jonathan M. Loree, Van K. Morris et al. · Annals of Oncology · 2018 · 240 citations · Full text

Medicine, Cancer Biology, Oncology +17

Survival improvement for patients with metastatic colorectal cancer over twenty years

Fadl A. Zeineddine, Mohammad A. Zeineddine, Abdelrahman Yousef et al. · npj Precision Oncology · 2023 · 174 citations · Full text

Medicine, Oncology, Molecular Oncology +5

Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer

Alain R. Thierry, Brice Pastor, Zhi-Qin Jiang et al. · Clinical Cancer Research · 2017 · 93 citations · Full text

Medicine, Genetics, Oncology +17

Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <i>BRAF</i>^V600E metastatic colorectal cancer.

Van K. Morris, Christine M. Parseghian, Michelle Escano et al. · Journal of Clinical Oncology · 2022 · 78 citations

Medicine, Oncology, Pharmacology +17

Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in <i>RAS/RAF</i> Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy

Christine M. Parseghian, Ryan Sun, Melanie Woods et al. · Journal of Clinical Oncology · 2022 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17